Do drug package inserts meet the rules and regulations of Iran’s Food and Drug Administration in terms of informing patients?

Tahereh Eteraf-Oskouei ¹ , Saeid Abdollahpour ¹ , Moslem Najafi ¹ , Vahideh Zarea Gavgani ^2,3 *

Cited by CrossRef: 4

1- Zheng Y, Tang Y, Tseng H, Chang T, Li L, Chen P, Tang Y, Lin X, Chen X, Tang K. Evaluation of quality and readability of over-the-counter medication package inserts. Research in Social and Administrative Pharmacy. 2022;18(9):3560 [Crossref]

2- Nualdaisri P, Corlett S, Krska J. Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature. Drug Saf. 2021;44(4):421 [Crossref]

3- Anantharamu T, Narain N, Mathur A, Roy P, Gupta A. Package Inserts. 2023;16(1):66 [Crossref]

4- Marques L, Vasconcelos R, Baldoni A, Pestana A, Chequer F. Cardiovascular drug labeling: Do they have information on necessary precautions for older people?. Geriatr Gerontol Aging. 2020;14(3):196 [Crossref]